Preliminary Analysis of the Presence of Bacterial Azurin Coding Gene in CRC Patients and Correlation with the Microbiota Composition

Front Biosci (Landmark Ed). 2022 Nov 11;27(11):305. doi: 10.31083/j.fbl2711305.

Abstract

Background: Azurin, a bacterial cupredoxin firstly isolated from the bacterium Pseudomonas aeruginosa, is considered a potential alternative therapeutic tool against different types of cancer.

Aims: In this work we have explored the relationship possibly existing between azurin and colorectal cancer (CRC), in light of the evidence that microbial imbalance can lead to CRC progression.

Methodology/results: To this aim, the presence of azurin coding gene in the DNA extracted from saliva, stool, and biopsy samples of 10 CRC patients and 10 healthy controls was evaluated by real-time PCR using primers specifically designed to target the azurin coding gene from different bacterial groups. The correlation of the previously obtained microbiota data with real-time PCR results evidenced a "preferential" enrichment of seven bacterial groups in some samples than in others, even though no statistical significance was detected between controls and CRC. The subset of azurin gene-harbouring bacterial groups was representative of the entire community.

Conclusions: Despite the lack of statistical significance between healthy and diseased patients, HTS data analysis highlighted a kind of "preferential" enrichment of seven bacterial groups harbouring the azurin gene in some samples than in others.

Keywords: Pseudomonas aeruginosa; azurin; colorectal cancer; microbiota; real-time PCR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azurin* / genetics
  • Genes, Bacterial
  • Humans
  • Microbiota* / genetics
  • Pseudomonas aeruginosa / genetics

Substances

  • Azurin